If you missed the live event, you can view the recorded content below.
A live event held on Thursday 7 October 2021
Chair: Dr Robin Howe, National Clinical Lead for Public Health Wales Microbiology
Welcome & introduction
Dr Robin Howe, National Clinical Lead for Public Health Wales Microbiology – View bio
The redefinition of the “I” category and ATU
Dr Mandy Wootton, Consultant Scientist / Operational Manager, Specialist Antimicrobial Chemotherapy Unit, Public Health Wales, University Hospital of Wales – View bio
Implementing the changes – Scotland
Dr Mairi MacLeod, Consultant Microbiologist, Glasgow Royal Infirmary & Chair of Scottish Microbiology and Virology Network (SMVN) AMR Diagnostics subgroup
Implementing the changes – Wales
Dr Lim Jones, Consultant Microbiologist, Public Health Wales, Cardiff
Differences between UK and EUCAST use aminoglycosides
Professor Alasdair MacGowan, Consultant in Infection at North Bristol NHS Trust and Professor of Antimicrobial Therapeutics at the University of Bristol – View bio
Panel discussion and Q&A
Chaired by Dr Robin Howe, National Clinical Lead for Public Health Wales Microbiology – View bio
For any queries regarding this event, please contact Esme Carruthers.